Clinical trial
Long Term Effects of Hydroxyurea Therapy in Children With Sickle Cell Disease
NCT00305175 · St. Jude Children's Research Hospital, Other · Completed
Key facts
| NCT number | NCT00305175 |
|---|---|
| Title | Long Term Effects of Hydroxyurea Therapy in Children With Sickle Cell Disease |
| Official title | Long Term Effects of Hydroxyurea Therapy in Children With Sickle Cell Disease |
| Lead sponsor | St. Jude Children's Research Hospital, Other |
| Collaborators | Children's Hospital Medical Center, Cincinnati |
| Status | Completed |
| Study type | Observational |
| Conditions | Sickle Cell Disease |
| Enrollment | 260 |
| Start date | Mar 3, 2006 |
| Primary completion | Apr 23, 2015 |
| Completion | Apr 23, 2015 |
| First posted | Mar 21, 2006 |
| Last update posted | Jul 28, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: